The Wellness Recovery Action Plan®, or WRAP®, is an evidence based practice that is used world-wide by people who are dealing with mental health challenges as well as medical conditions. Diabetes, weight gain, pain management, addictions, smoking, and trauma are just some of the many life challenges that can benefit from WRAP. WRAP can also be used as a framework to guide relationships in peer support, recovery groups, agencies, and organizations.
WRAP is being used in schools, prisons, hospitals, and veterans’ facilities. It is used with people of all ages who want to attain the highest possible level of wellness. It was originally developed by a group of people who lived with mental health difficulties and were searching for ways to resolve their wellness issues. WRAP was their answer, and it can be used by anyone looking to develop a plan to manage a path to wellness.
WRAP involves listing your personal resources, your Wellness Tools, and then using those resources to develop an Action Plan to use in specific situations which you determine. WRAP is adaptable for any situation and can include a Crisis Plan or Advance Directive.
WRAP is for Life! – It is for everyone, anytime, and for any of life’s challenges.
Interesting article, placebo’s as effective as meds.
Drug companies have a problem: they are finding it ever harder to get painkillers through clinical trials. But this isn’t necessarily because the drugs are getting worse. An extensive analysis of trial data1 has found that responses to sham treatments have become stronger over time, making it harder to prove a drug’s advantage over placebo.
The change in response to placebo treatments for pain, discovered by researchers in Canada, holds true only for US clinical trials. “We were absolutely floored when we found out,” says Jeffrey Mogil, who directs the pain-genetics lab at McGill University in Montreal and led the analysis. Simply being in a US trial and receiving sham treatment now seems to relieve pain almost as effectively as many promising new drugs. Mogil thinks that as US trials get longer, larger and more expensive, they may be enhancing participants’ expectations of their effectiveness.
See the entire article here: http://www.nature.com/news/strong-placebo-response-thwarts-painkiller-trials-1.18511?%3Fftcamp=crm%2Femail%2F%2Fnbe%2FFirstFTEurope%2Fproduct